SCHEMBL17440751

SCHEMBL17440751

CC(=O)CCc1cccc(Br)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
IAPP P10997 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
FAAH O00519 1/20 0.39
HPGD P15428 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
KDM4E B2RXH2 3/20 0.38
LMNA P02545 3/20 0.37
GRM5 P41594 1/20 0.36
KCNH2 Q12809 2/20 0.36
MAOA P21397 2/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
SLC6A2 P23975 1/20 0.36
RAB9A P51151 1/20 0.36
SLC6A3 Q01959 1/20 0.36
PARP1 P09874 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7445471 0.85 KEAP1 (0.44) ALDH1A1NPSR1FAAHHPGDKDM4E
SCHEMBL31715510 0.83 NPSR1 (0.43) ALDH1A1NPSR1FAAHHPGDGRM5
SCHEMBL6564804 0.83 NPSR1 (0.43) ALDH1A1NPSR1FAAHHPGDGRM5
SCHEMBL17441457 0.83 KCNH2 (0.37) ALDH1A1NPSR1FAAHHPGDGRM5
SCHEMBL23599140 0.83 KDM4E (0.46) ALDH1A1NPSR1FAAHHPGDSMN1; SMN2
SCHEMBL1511343 0.80 CYP4F2 (0.48) ALDH1A1SMN1; SMN2KDM4ELMNACYP1A2
SCHEMBL19837458 0.79 ALDH1A1 (0.47) ALDH1A1IAPPNPSR1HPGDSMN1; SMN2
SCHEMBL4573420 0.79 TRPM5 (0.45) ALDH1A1IAPPNPSR1HPGDSMN1; SMN2
SCHEMBL17440498 0.79 KCNH2 (0.38) ALDH1A1NPSR1FAAHHPGDSMN1; SMN2
SCHEMBL7437586 0.79 SMN1; SMN2 (0.47) ALDH1A1FAAHHPGDSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3322702-A1 CYANOPYRROLIDINES AS DUB INHIBITORS FOR THE TREATMENT OF CANCER Mission Therapeutics Limited (GB) 2018-05-23 EP disclosed
WO-2017009650-A1 CYANOPYRROLIDINES AS DUB INHIBITORS FOR THE TREATMENT OF CANCER MISSION THERAPEUTICS LIMITED (GB) 2017-01-19 WO disclosed
WO-2016011390-A1 IRAK4 INHIBITING AGENTS BIOGEN MA INC. (US) 2016-01-21 WO disclosed